CHRO, EVP of People and CultureShow more
GM, PlushcareShow more
Chief Medical OfficerShow more
EVP, General Counsel, and CCOShow more
EVP, Accolade Care SolutionsShow more
EVP, GM, Enterprise and Strategic SolutionsShow more
EVP, GM, Mid-MarketShow more
Assoc. CMO, Accolade; CMO, PlushcareShow more
SVP, Investor RelationsShow more
SVP, GM, Health Plan and EnterpriseShow more
SVP, Solutions Management and MarketingShow more
SVP, GM Govt SolutionsShow more
SVP, Chief Information Security OfficerShow more
SVP, Product ManagementShow more
VP, Strategy, Corporate Development and PartnershipsShow more
EVP, Advocacy DevelopmentShow more
SVP, Clinical OperationsShow more
Elizabeth Nabel, MD is a member of the audit committee and joined Accolade board of directors in 2021.
Dr. Nabel is an executive leader at ModeX Therapeutics, which develops innovative immunotherapies for cancer and infectious diseases.
She previously served as the president of Brigham and Women’s Hospital and was the first chief health and medical advisor to the National Football League. In her role as director of the National Institute of Health’s National Heart, Lung and Blood Institute, she became known for her advocacy efforts that resulted in the Heart Truth campaign, which features its signature iconic red dress.
Dr. Nabel is an elected member of the National Academy of Medicine of the National Academy of Sciences. She has been named one of the nation’s top leaders in medicine by Modern Healthcare magazine, Becker’s Hospital Review and as one of Boston’s “50 Most Powerful People” by Boston magazine. She serves on the boards of Medtronic, Moderna, Lyell and the Lasker Foundation.
She attended Weill Cornell Medical College and completed her internal medicine and cardiology training at Brigham and Women’s Hospital and Harvard University.
Jeff Brodsky is a member of the compensation committee and joined Accolade board of directors in 2021.
Brodsky is vice chairman at Morgan Stanley and a member of its operating committee. Brodsky works with management and the board on critical strategic issues related to executive talent, succession and diversity and inclusion. He also helps lead the firm’s COVID-19 response and brings direct experience in acquisition integration, most recently E*Trade and Eaton Vance.
During more than 30 years at Morgan Stanley, Brodsky held a variety of leadership roles in human resources, culminating in more than 10 years as the firm’s chief human resources officer.
Brodsky serves on the Safe Horizon board of directors and is an executive in residence at the University of Michigan’s Ross School of Business, where he previously served on the school’s advisory board. He earned a B.S. in accounting from Binghamton University.
Cindy R. Kent is a member of the nominating and governance committee and joined Accolade board of directors in 2021.
Kent has been working in the healthcare industry for more than 25 years. She’s the current executive vice president and president of senior living community operations at Brookdale Senior Living, America’s largest senior living company with over 700 facilities across the U.S. Kent oversees Brookdale’s day-to-day senior living operations and is responsible for revenue and profitability growth. She also currently sits on the Board of Trust at Vanderbilt University.
Kent was named one of Savoy Magazine’s “2020 Most Influential Black Executives in Corporate America.” She previously held executive leadership positions at 3M, Medtronic and Eli Lilly. She is a Henry Crown Fellow of the Aspen Institute and was an independent board director at Best Buy.
Kent holds a Master of Divinity as well as an MBA in marketing from Vanderbilt University. She completed her B.S. in industrial engineering and management sciences at Northwestern University.
Jeff Jordan is a member of the compensation committee and joined Accolade board of directors in 2016.
Jordan is a managing partner at Andreessen Horowitz where he serves on the boards of Accolade (Nasdaq: ACCD), Airbnb (Nasdaq: ABNB), Incredible Health, Instacart, Lookout, Neighbor, OfferUp, Pinterest (NYSE: PINS), Shef and Wonderschool.
He was previously CEO and then executive chairman of OpenTable, where he led the company during a period of accelerated domestic and international growth and oversaw its initial public offering during one of the longest tech IPO droughts in recent history.
Prior to OpenTable, Jordan was senior vice president and general manager of eBay North America where he oversaw eBay's early growth into one of the internet's leading e-commerce brands. In this role, he drove the successful acquisitions of PayPal and Half.com and went on to become president of PayPal, where he was responsible for establishing the company as the global standard for online payments.
Before joining eBay, Jordan was chief financial officer of Hollywood Entertainment and president of Reel.com. He also worked as senior vice president of finance for The Disney Stores at The Walt Disney Company and prior held various positions at the Boston Consulting Group. He serves on the boards of the DAPER Investment Fund, The GSB Trust and the Stanford School of Engineering Advisory Council.
Jordan holds an MBA from Stanford University Graduate School of Business and a B.A. in political science and psychology from Amherst College. Jordan is an active mentor and leader in the Bay Area community. He also runs a regular basketball game that connects young people with established tech industry vets.
Peter Klein is a member of the audit committee and joined Accolade board of directors in 2019.
Klein is the lead independent director of the board of directors and has nearly 25 years of experience as a senior finance executive. He served as chief financial officer of WME, a global leader in sports and entertainment marketing, from January 2014 to June 2014. Prior to that, he served as chief financial officer of Microsoft Corp. from November 2009 to May 2013.
Klein spent more than 11 years at Microsoft in a variety of executive roles, including chief financial officer of the server and tools and Microsoft business divisions. From 1990 to 2002, he held senior finance roles with McCaw Cellular Communications, Orca Bay Capital, Asta Networks and Homegrocer.com. He currently serves on the board of directors of F5 Networks, Denali Therapeutics and Sarcos Robotics. Klein holds a B.A. from Yale University and an MBA from the University of Washington.
Dawn Lepore is a member of the audit, and the nominating and governance committees and joined Accolade board of directors in 2019.
Lepore is the former CEO and chairman of the board of drugstore.com, an online retailer of health, beauty and wellness products, which she led from 2004 until its acquisition by Walgreens in 2011.
Lepore repositioned drugstore.com to focus on over-the-counter, beauty and vision products, which led the company to record revenues. Prior to drugstore.com, Lepore spent more than 21 years at Charles Schwab in a variety of leadership roles, including launching Schwab’s highly successful e-commerce business. In her tenure there, she was vice chairman of technology, chief information officer and held strategic positions in operations, administration, business strategy and worked as an active trader.
Lepore has been recognized professionally by multiple industry groups, including Fortune magazine, which nominated her four times as one of the “50 Most Powerful Women in American Business.” She’s also been recognized by the National Organization for Women at their Aiming High Conference, one of InformationWeek’s “Chiefs of the Year” and Future Banker magazine as one of the “Ten Hottest CIOs.”
In addition to Accolade, she serves on the boards of loanDepot (NYSE), RealNetworks and Servco Pacific Inc. Lepore is a graduate of Smith College.
Tom Neff is a member of the compensation committee and joined Accolade board of directors in 2010. Neff has been with Spencer Stuart, the global executive search and leadership advisory firm, since 1976. He currently serves as Spencer Stuart’s U.S. Chairman and previously managed the worldwide firm for eight years. Prior to that, he was a principal with Booz Allen Hamilton. Neff began his career as a consultant with McKinsey & Company. After McKinsey, Neff held a senior marketing position with TWA.
He served for 16 years on the board of directors of ACE Limited (now Chubb), with more than $30 billion in revenue, as well as three other public companies: Hewitt Associates, Macmillan and Exult, until they were acquired. In each case, he chaired the compensation and/or nominating committees. He currently serves on the board of Atlantic Avenue Acquisition Corp. (NYSE). Neff also previously served on the board of Lord Abbett & Co., the mutual fund company with assets in excess of $150 billion.
He earned his B.S. in industrial engineering from Lafayette College where he is a trustee emeritus. He also holds an MBA from Lehigh University.
Rajeev Singh is the CEO and chairman of the Board of Directors at Accolade.
Singh joined Accolade as CEO in November 2015. Prior to joining Accolade, Singh co-founded Concur, the global leader in travel and expense management, in 1993. Concur went public (NASDAQ: CNQR) in 1998, and grew to more than $800 million in revenues, over 4,000 employees and more than 25,000 customers before being acquired by SAP AG for $8.3 billion in 2014. Singh was the president, chief operating officer and a member of the board of directors of Concur.
Singh serves on the board of Avalara (NYSE: AVLR), a top provider of cloud-based tax compliance automation for businesses; Amperity, an intelligent customer data platform; Seattle Children’s Hospital Foundation; and the University of Washington Foundation.
Pat Wadors is a member of the nominating and governance committee and joined Accolade board of directors in 2020.
Wadors is the chief talent officer for Procore, the digital workflow company that focuses on improving the lives of everyone in the construction industry. In this role, Wadors implements her longtime focus on building high-performing and healthy companies that scale to create amazing employee experiences for Procore’s people around the world.
Prior to joining Procore in November 2020, Wadors was the chief talent officer of ServiceNow. Prior to that, she was the senior vice president, global talent organization at LinkedIn, where she focused on recruiting and developing top talent, driving organizational transformation, supporting a highly engaged workforce and expanding LinkedIn’s global footprint.
Wadors has also held human resources leadership positions at Plantronics, Yahoo!, Align Technology and Applied Materials. Wadors currently serves on the board of directors for UKG (Ultimate Kronos Group).
She earned her B.S. in business management with a concentration in human resources management and a minor in psychology from Ramapo College of New Jersey.
Joseph R. Betancourt, is director of the Disparities Solutions Center, director of Multicultural Education for Massachusetts General Hospital, associate professor of medicine at Harvard Medical School and co-founder of Quality Interactions, Inc. Dr. Betancourt is an expert in quality of care, disparities, and cross-cultural care and communication. He has worked with more than 100 organizations focused on improving quality for vulnerable populations throughout the country as part of the Disparities Leadership Program, and created and deployed a portfolio of Quality Interactions e-learning programs to more than 125,000 healthcare professionals nationwide.
Larry Kaiser is CEO of the Temple University Health System, senior executive vice president for the Health Sciences, and dean of Temple University School of Medicine. He specializes in thoracic surgery, and his research interests include lung cancer, malignant mesothelioma and mediastinal tumors. He is the author or co-author of more than 13 books and 250 original papers.
As Chief Medical Officer of Accolade, Dr. Shantanu Nundy oversees the company’s clinical strategy and solutions to improve health outcomes, experience and relationships individuals and families have with their providers. Dr. Nundy is a practicing primary care physician and technologist with expertise in combining medicine and innovation with deep knowledge of the healthcare industry and global health policy. Prior to joining Accolade, Dr. Nundy served as senior technology advisor in the World Bank Group’s Health, Nutrition and Population Global Practice. In this role, he accelerated adoption of health innovation and technology across the bank’s $15 billion healthcare portfolio in low- and middle-income countries. Dr. Nundy previously served as director of the Human Diagnosis Project (a healthcare artificial intelligence startup company) and managing director for Clinical Innovation at Evolent Health (a population health and predictive analytics company) where he improved hospital and chronic disease outcomes for more than two million individuals in the U.S. He is also co-inventor of SMS-DMCare (an automated text messaging software for individuals with diabetes). It is one of the first mHealth interventions to demonstrate improved health and lower costs. It was adopted by the World Health Organization’s eHealth Compendium. Dr. Nundy work has been recognized by the MacArthur Foundation and has been featured in Wall Street Journal, Forbes, The Atlantic and WIRED. He is the author of Stay Healthy at Every Age, a Wall Street Journal top five book in health and wellness of 2010. He practices primary care at Mary’s Center, a federally-qualified health center serving a large, immigrant community in Washington, D.C. He earned his bachelor’s degree at Massachusetts Institute of Technology, his doctor of medicine degree at Johns Hopkins and his Master of Business Administration degree at the University of Chicago.
Jennifer S. Lerner is professor of public policy at the Harvard Kennedy School of Government, and an internationally recognized expert in decision science. The first psychologist in the history of the Harvard Kennedy School to receive tenure, her work draws insights from psychology, economics and neuroscience in order to explain human judgment and decision making. Together with colleagues, she has developed a theoretical framework that successfully predicts the effects of specific emotions on specific judgment and choice outcomes. Applied widely, the framework has been especially useful in predicting emotional effects on decisions involving risk and valuation. The lead author in seminal research papers, Dr. Lerner has earned many prestigious awards including the Presidential Early Career Award for Scientists and Engineers — the highest academic honor the U.S. government gives to scientists and engineers in early stages of their careers. In addition to research, Dr. Lerner is also devoted to graduate and executive-level education by founding and directing Harvard’s Leadership Decision Making executive program.
Saul Weiner is professor of medicine, pediatrics and medical education and vice provost of planning and programs at the University of Illinois at Chicago. He is also deputy director of the Veterans Affairs Center of Innovation for Complex Chronic Healthcare, funded by the VA’s Division of Health Services Research & Development. His background is in internal medicine and pediatrics, and his research has focused on patient-centered decision-making and the challenge of individualizing care. Dr. Weiner is also co-founder and co-principal of the Institute for Practice and Provider Performance Improvement. He was named the University of Illinois at Chicago’s Distinguished Researcher of the Year for the clinical sciences in 2013.